Business
Natco Pharma Q4 Result FY26: Net Profit Falls 34%, Revenue Slumps 37%, and the Revlimid Era Starts Fading
Company Introduction: The Niche Pharma Specialist Behind India’s Global Generic Success Natco Pharma Limited has built a unique position within…